Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Candel Therapeutics granted stock options to purchase 63,000 shares to three new employees as inducement awards. The options carry an exercise price of $8.30 per share and were issued under Nasdaq Listing Rule 5635(c)(4) to facilitate hiring.
Key figures
- Offering Price
- 8.3
- Shares Offered
- 63000
- Vesting schedule
- 25% at 1 year, 75% over 36 months
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.